|
Benjamin Glaser, M.D.
Head, Endocrinology and Metabolism Service
Internal Medicine Division
Hadassah Hospital
Tel: 02-6776599
Fax: 02-6437940
Email: beng@cc.huji.ac.il
Dr. Glaser is a graduate of the University of Maryland Medical
School in Baltimore, Maryland, U.S.A. After training in Internal
Medicine at the Washington Hospital Center in Washington D.C.,
Dr. Glaser completed training in Endocrinology and the University
of Michigan Medical School, Ann Arbor, Michigan. Dr. Glaser
came to Israel in 1981 to work in the Endocrine Clinics of
the General Health Fund in Haifa. In 1984 he moved to Jerusalem
to join the Department of Endocrinology and Metabolism at
the Hadassah Hospital. His research interests include the
identification of genetic risk factors for Type 2 Diabetes
Mellitus, and the study of a rare genetic disease, Hyperinsulinism
of Infancy. He is a founding member of the European Network
for the Study of Hyperinsulinism in Infancy, a multinational
consortium committed to the study of all aspects of this rare
disease. Recently he has initiated a project aimed at identifying
novel strategies for in vivo and in vitro beta-cell expansion.
This project that is directly related to plans to develop
a pancreatic islet transplant facility at the Hadassah Hospital,
under the auspices of the Endocrinology and Metabolism Service.
Dr. Glaser has published more than 100 research papers and
reviews, and is on the review committees of several major
journals in the field of Endocrinology and Diabetes. Since
April, 2001 Dr. Glaser has served as the Head of the Endocrinology
and Metabolism Service in the Division of Internal Medicine
of the Hadassah University Hospital in Jerusalem.
|